development & production

Commercialization of protein-based vaccines & biopharmaceuticals

Free
Message: How disappointed would you be...

The results were not built into the price, if they were than there is no need for the drop today.

The drop today is impatient investors who don't realize the tru potential of the news release and can not see the implications of the successful Phase I. and who thought it would sky rocket with news and when they didn't see that, they dumped in the market, CIBC being one of the big ones

The drop today is because we were not class leading, we were better than most except one company but the cost of MDG's technology and time to bring it to the market will make MDG a dominant player in the vaccice market.

There is a lot things at work behind close doors now that we acheived the milstone of successful Phase I.

I know of a few investors including myself who acquired more this AM in the mid .60's

Share
New Message
Please login to post a reply